News

Intezyne, a clinical-stage biopharmaceutical company developing novel anti-cancer therapies, announced that it has partnered with Exosome Diagnostics, a privately held company focused…
Read More...

Sartorius Stedim Biotech (SSB) announced the launch of the ambr 250 high throughput (ht) perfusion, a new automated parallel bioreactor system. It has been specially designed for rapid…
Read More...

X-Chem, Inc. announced the appointment of Christelle Huguet, Ph.D. as Chief Scientific Officer, along with an executive leadership appointment for Matthew Clark, Ph.D. as Senior Vice…
Read More...

Dr. Reddy’s Laboratories Ltd announced that it has launched Levocetirizine Dihydrochloride Tablets USP, 5 mg, an over-the-counter therapeutic equivalent generic version of Xyzal Allergy…
Read More...

Dalton Pharma Services has declared the signing of a drug development and manufacturing services agreement with Oryn Therapeutics, an American biotechnology firm committed to the…
Read More...

Certara announced the launch of its Quantitative Systems Pharmacology (QSP) Immuno-oncology Simulator Consortium. QSP combines computational modeling and experimental methods to…
Read More...

Proteostasis Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for PTI-428, the Company’s cystic fibrosis transmembrane…
Read More...

MEDISCA announced that an out-licensing agreement has been signed with California-based Torrey Hills Technologies Inc., for its innovative ointment mill cleaning tool for ProMill™. The…
Read More...

One in 10 people in America is fighting a rare disease, or a disorder that affects fewer than 200,000 Americans. Although there are more than 7,000 rare diseases that collectively…
Read More...

Bio-Techne has released MimEX™ GI, a new product line for generating 3-dimensional (3-D) gastrointestinal tissue on a 2-D surface. 3-D cell culture and organoid models of the…
Read More...

Ionis Pharmaceuticals and Akcea Therapeutics announced an exclusive, worldwide license by Ionis to Akcea for inotersen and AKCEA-TTR-LRx, formerly IONIS-TTR-LRx, in a transaction…
Read More...

Recipharm, the contract development and manufacturing organisation (CDMO), announces its new Blow-fill-seal machinery is now operational following a substantial investment last year at…
Read More...

PAREXEL International Corporation announced an alliance with CHA Medical Group (CHA) to enhance early phase clinical development in Korea. The collaboration is designed to provide…
Read More...

Boehringer Ingelheim and Vanderbilt University announced the expansion of their successful existing collaboration to develop novel anti-cancer compounds. The expanded research…
Read More...

Illumina asserted the appointment of Dr. Phil Febbo who is a Leading physician scientist, as Chief Medical Officer (CMO), starting March 26, 2018. In his new role, Dr. Febbo will be…
Read More...

The American Society for Radiation Oncology declared a new clinical guideline for the usage of whole breast radiation therapy for breast Cancer augmenting the population of patients…
Read More...

Connexient which is the healthcare leader in enterprise digital wayfinding , mapping and indoor navigation services set to roll out enhanced software version, MediNav Navigator 3.0.…
Read More...

Merriimack Pharmaceuticals which is a clinical-stage oncology company focused on biomarker-defined cancers asserted that it is augmenting enrollment in the ongoing randomized Phase 2…
Read More...

BioVentrix announced successful treatment of the first patient at the Cardiovascular Institute of the South in the ALIVE pivotal clinical trial. The trial is designed to demonstrate the…
Read More...

Check-Cap which is a clinical-stage medical diagnostics company engaged in the development of C-Scan which is an ingestible capsule for preparation-free, colorectal cancer screening,…
Read More...